Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

NEXT STORY
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021
PREV STORY
Oyster Point Pharma Reports Second Quarter 2021 Financial Results and Recent Business Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus participera à la 13ème Conférence annuelle sur les biotechnologies de Citi

UTRECHT, Pays-Bas, 30 août 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), une société d'immuno-oncologie ...

author_avatar
NASDAQ Market News

BeiGene to Present at the Deutsche Bank 43rd Annual Health Care Conference

CAMBRIDGE, Mass., and BEIJING, China, May 04, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has ...

author_avatar
NASDAQ Market News